Posted on Leave a comment

Hong Kong to ban CBD*

Flag of Hong Kong

« The trade and the public should arrange early disposal of any CBD products in their possession to avoid contravention of the law. »

government spokesperson

Cannabis extract to be put in the same category as heroin and cocaine, reports the Hong Kong Post.*

Hong Kong will outlaw cannabidiol (CBD) by February, the government announced on Thursday, placing it in the same category as heroin, cocaine and methamphetamine with users facing hefty jail time. The move is expected to wipe out businesses in the Chinese finance hub that had, until now, been able to sell CBD-infused products such as beers, coffee and health supplements.*
The changes to Hong Kong’s drug control laws, pending a final round of vetting by the city’s rubber-stamp legislature, will take effect from Feb 1.*
“The trade and the public should arrange early disposal of any CBD products in their possession to avoid contravention of the law,” a government spokesperson said.*
After the deadline, anyone who possesses or consumes CBD faces up to seven years in jail and fines of up to HK$ 1 million (US$ 127,000). CBD will be put alongside more than 200 substances classified as “dangerous drugs”, which all carry the same strict penalty.*
CBD is one of the active ingredients of cannabis but does not have psychoactive properties. Users have touted its relaxing and pain-relieving properties, though Hong Kong’s Security Bureau said such claims “lack authoritative scientific proof”.*
CBD is legal in some Asian nations including Thailand and Japan, as well as in the United States and parts of Europe.
John Lee, a former police officer who became Hong Kong’s chief executive in July, has taken a hard line on drugs.*
“Cannabis is a drug, and the government will categorise CBD as a dangerous drug … to protect the public’s health,” he said in a speech last month.*
China last year banned the use of CBD in cosmetic products.*

* article original

** image

*** ndlr. : –.

Posted on Leave a comment

Maryland legalizes cannabis*

Flag of USA

« 65.3% of Marylanders voted to legalize marijuana for recreational use. »

State of Maryland

With 65.3% of the vote, Marylanders voted to legalize marijuana for recreational use. Such legalization was also subject to referendum in four other states, Arkansas, Missouri, North Dakota and Dakota, reports the Swiss Radio Television (RTS).*

* article original

** image

*** ndlr. : –.

Posted on Leave a comment

A project to legalize cannabis presented by the German government

« The purchase and possession of “a maximum amount of 20 to 30 grams” will be allowed for personal consumption. »

Health Minister Karl Lauterbach

The German government agreed on Wednesday 26 October on a framework for the legalization of recreational cannabis, which would make Germany one of the most liberal countries in Europe. To come into effect, it must be approved by the European Commission, reports the Swiss Radio Television (RTS).

Under the new legal framework, which could come into effect as early as 2024, the production and trade of cannabis would be placed under “public control” for the entire supply chain. The purchase and possession of “a maximum quantity of 20 to 30 grams” will be allowed for personal consumption, said Health Minister Karl Lauterbach.

The text also authorizes the cultivation of three cannabis plants per adult for personal use. The sale would be “strictly controlled”, advertising would be prohibited and packaging would be largely regulated. Use by those under 18 would continue to be strictly prohibited.*

“We do not want to make the same mistakes as with alcohol or tobacco, because young people and children are those who react most to the promises of the advertising industry,” said the government commissioner for drugs and addiction.

Backing from Europe*

“We are in a phase where we are examining whether the outlines we have drawn up in this document are compatible with international and European law,” stressed the social-democrat minister.

If this is not the case, the document will not become law, he said, but he was relatively confident.

Ineffective repression

This reform comes in a context of increasing cannabis consumption in Germany. In 2021, the number of consumers or consumers is estimated at about four million people, a quarter of which were aged 18 to 24 years.*

The German government takes note, moreover, of the inefficiency of the current policy. A purely repressive policy that has “failed”, conceded the Minister of Justice.

“That’s why we want to legalize the use of cannabis in a responsible way. This means better quality products and health protection” and a relief for the justice system that can “focus on more important things,” he said on Twitter. *

Promised reform*

The legalization intends to address health and security issues, fighting against organized crime funded by the black market. It is a flagship reform promised by the center-left coalition when it was formed last December.*

The social democrats have long been against it. Minister Karl Lauterbach himself admits that he has changed his mind in the last two years. The conservative right, on the other hand, remains generally opposed.

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

The sale of cannabis in pharmacies in Basel postponed indefinitely

Drapeau suisse

« This can take weeks or months. »

Regine Steinauer, Head of the Addiction Service of the Basel-Stadt Department of Health

The launch of the controlled sale of cannabis in pharmacies in Basel, scheduled for next Thursday, has been postponed until further notice. The products intended for this pilot project do not meet the required biological criteria, because they contain residues of phytosanitary products, reports the Swiss Radio Television (RTS).

The cannabic products grown by the firm Pure Production in Zeiningen (AG), commissioned by the canton of Basel-Stadt, have narrowly failed the quality test, said Friday the cantonal department of health.*

They will now be analyzed by an independent laboratory. In addition, the authorities will study the possibility of using other cannabic products from the same firm or other producers.*

The residues of phytosanitary products discovered on the cannabis provided by the company commissioned are not allowed in the organic mode of cultivation, says Regine Steinauer, head of the service of addictions of the department of health of Basel-City.*

No deadline*

The duration of the postponement is not yet known. “It could be weeks or months,” adds Regine Steinauer. In mid-August, the canton had announced that the controlled sale of cannabis in nine selected pharmacies would begin on September 15, as part of the first pilot project of its kind in Switzerland.*

A total of 370 selected regular cannabis consumers are expected to participate. Approximately 700 people have registered to participate in the study. The canton will contact the participants from mid-September.*

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

Access to medical cannabis will be facilitated for patients

Drapeau suisse

« It will no longer be necessary to request an exceptional authorization from the FOPH to use cannabis for medical purposes. The new regulation will particularly benefit people suffering from severe chronic pain and spasticity. »

Federal Office of Public Health

The Federal Council intends to facilitate access to medical cannabis for patients. At its meeting on 22 June 2022, it therefore decided to lift the ban on medical cannabis in the Narcotics Law (LStup). An exceptional authorization from the Federal Office of Public Health (FOPH) is no longer required for medical prescription. However, the sale and consumption of cannabis for non-medical purposes remains prohibited. The change in the law will come into force on August 1, 2022, reports the communication service of the Federal Office of Public Health.*

As of August 1, 2022, medical cannabis will be more readily available to patients. The decision to use a cannabis-based medicine for therapeutic purposes will be made by the doctor in consultation with the patient. It will no longer be necessary to apply to the FOPH for an exceptional authorization to use medical cannabis. The new regulation will particularly benefit people suffering from severe chronic pain and spasticity.*

Growing demand*

Until now, it was forbidden to cultivate or import cannabis or to process it into medical preparations without an exceptional permit. Furthermore, the treatment of patients with cannabis-based medicines not subject to authorization was only possible with an exceptional authorization from the FOPH and only in justified cases.*

The demand for such authorizations has increased in recent years. These time-consuming administrative procedures delay treatments, and the current situation no longer reflects the exceptional character provided for by the law on narcotics. The Federal Council therefore submitted to Parliament an amendment to the law to remove the ban on cannabis for medical purposes, which was adopted in March 2021. A narcotics prescription will still be required for such medicines.*

Lack of evidence of effectiveness for reimbursement*

The adaptation of the law does not change the conditions for reimbursement of cannabis-based medicines by the compulsory health insurance. Currently, they are only reimbursed in exceptional cases. The Federal Council has examined whether there is a need for action in this area. However, the available evidence on the efficacy and suitability of cannabis-based medicines is currently insufficient to allow for general coverage.*

The data that will now be collected by the Confederation on treatments with cannabis-based medicines may prove useful. The mandatory data collection serves to observe the evolution of the prescription of these drugs and to obtain more evidence on their effects. It is limited to the first seven years after the law is changed. The data obtained can support, but not replace, a specific claim for reimbursement of cannabis-based medications.*

Need to adapt the implementing legislation

Implementation of the law change requires adaptations to the Ordinance on the Control of Narcotics (OCStup) and the Ordinance on the Schedules of Narcotics (OCStup-DFI), scheduled for August 1, 2022. In particular, the control measures for the cultivation of cannabis for medical purposes will be regulated in detail and Swissmedic will assume responsibility for them once the law is amended.*

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

Will the consumption and production of recreational cannabis soon be legal in Switzerland?

Drapeau suisse

« If hemp cultivation brings a better margin than beet or rapeseed cultivation, it is clear that people will go for this kind of cultivation. The question of profitability will be a determining factor in this respect. »

Michel Darbellay, Swiss Farmers’ Union

The commissions of the parliament agree to lift the current ban on the consumption and production of recreational cannabis in Switzerland. The aim would be to dry up the black market by making the sale of cannabis legal, reports RTS.*

Heinz Siegenthaler, national councilor of the center, initiated the change of the cannabis law. The farmer already uses legal hemp to produce oil for food but he wants to lift the total ban.*

But would this legalization be an opportunity for Swiss agriculture? In Canada and California, cannabis has been legalized to dry up the black market, but for Michel Darbellay of the Swiss Farmers’ Union, the prospects are still uncertain.*

A growing market*

In Switzerland, 300’000 people regularly use cannabis for recreational purposes. The desired effect is found in the THC substance. However, it is forbidden to cultivate plants containing more than 1% THC in Switzerland.*

According to Heinz Siegenthaler, cannabis production “is not as easy as growing potatoes or beets, because the plants have to be protected so that young people can’t get access to them. But for innovative, modern farmers who are looking for something new, it is an opportunity. Currently, 180 Swiss farmers grow industrial hemp to produce fiber, tea or fodder.*

Legalization not always sufficient to face the black market*

“If the cultivation of hemp brings a better margin than the cultivation of beet or rape, it is clear that people will start to cultivate it. The question of profitability will be decisive in relation to that”, explains Michel Darbellay.*

The margin and the market are difficult to anticipate. In Canada, where recreational cannabis has been legal for three years, there is an overproduction, big companies buying up small growers and the black market remains important.*

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

Spasticity & Cannabis

Logo 86Avenue Sàrl
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Virginia governor signs bill legalising marijuana possession from July 1

Flag of the United States

“We are moving forward in a way that promotes equity, provides a clean slate to those with prior convictions, and reinvests in the communities harmed by over-criminalization”

Virginia Governor Ralph Northam

Virginia Governor Ralph Northam signed a bill that legalises the simple possession of marijuana, making the state the first in the U.S. south to allow the drug’s recreational use, the governor said, report Reuters.*

In a bid to tackle racial disparities in the prosecution of marijuana-related crimes, the state accelerated to July 1 its timetable to pass the legislation, rather than waiting until 2024.*

“Seventy-one days from now, Virginia will no longer police adults possessing small amounts of marijuana,” Northam said at Wednesday’s ceremonial signing of the bill.*

Northam cited a report by the Joint Legislative Audit and Review Commission that showed Black residents were more than three times as likely to be arrested for possessing small amounts of the drug.*

“We are moving forward in a way that promotes equity, provides a clean slate to those with prior convictions, and reinvests in the communities harmed by over-criminalization,” he said on Twitter.*

The legislation, signed a day after the informal April 20 pot holiday, also known as 4/20, allows anyone aged 21 or more to possess up to one ounce (28.4 grams) of marijuana.*

People in the state can cultivate up to four cannabis plants per home for personal use.*

NORML, a pro-marijuana group, celebrated the decision as an “extraordinary victory for cannabis justice” in the state.*

The timeline for the state to adopt provisions licensing commercial cannabis production and sales is July 1, 2024.*

On Monday, the U.S. House of Representatives passed legislation that lets banks provide services to cannabis companies in states where it is legal, a step towards levelling what analysts call a barrier to the development of a national industry.*

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

EU allows Lesotho’s MG Health to export cannabis flower for medicinal use

Flag of Europe

“What this means is that we have authorisation to export our products as an API into Germany and the wider European market. We expect to start in June.”

MG Health chief executive Andre Bothma

Lesotho start-up MG Health has become the first African cannabis-grower to win European Union permission to export cannabis flower for medicinal use – which can range from relieving chronic pain to treating spasms caused by multiple sclerosis, report Reuters.*

Lesotho has helped pioneer the nascent legal cannabis sector in Africa which could be worth more than $7.1 billion annually by 2023 if new laws are introduced, the African Cannabis Report said two years ago.

Launched in 2017, MG Health has its cultivation and modern processing facilities at a secluded location some 2,000 metres above sea-level in mountainous Lesotho, which is completely surrounded by South Africa.

MG Health chief executive Andre Bothma said the firm had received certification to export cannabis flower as an active pharmaceutical ingredient (API) under the EU’s Good Manufacturing Practices (GMP) protocol.

“What this means is that we have authorisation to export our products as an API into Germany and the wider European market. We expect to start in June,” he said on the sidelines of a media event with his Munich-based import partner, Drapalin Pharmaceuticals.

Besides the EU and Germany, Bothma said they also planned to enter the UK and Australian markets.

A growing number of countries around the world are either legalising or relaxing laws on cannabis as attitudes towards the drug change. They include several in Africa, such as South Africa, Rwanda, Morocco and Malawi. read more

MG Health currently produces around 250kg of packed cannabis flower a month on a pilot-scale production footprint of 5000 square meters. As soon as exports start, another 10,000 m2 of greenhouse space will be added, officials said.

“Our contract is for a minimum of two tonnes for the first year,” Bothma said.

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

Anxiety & Cannabis

Logo 86Avenue Sàrl
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.